'Italia LJ. Dynamic molecular and histopathological changes in the extracellular matrix and inflammation in the transition to heart failure in isolated volume overload. Am J Physiol Heart Circ Physiol 300: H2251-H2260, 2011. First published March 18, 2011 doi:10.1152/ajpheart.01104.2010 volume overload (VO) causes eccentric remodeling with inflammatory cell infiltration and extracellular matrix (ECM) degradation, for which there is currently no proven therapy. To uncover new pathways that connect inflammation and ECM homeostasis with cellular dysfunction, we determined the cardiac transciptome in subacute, compensated, and decompensated stages based on in vivo hemodynamics and echocardiography in the rat with aortocaval fistula (ACF). LV dilatation at 5 wk was associated with a normal LV end-diastolic dimension-to-posterior wall thickness ratio (LVEDD/PWT; compensated), whereas the early 2-wk (subacute) and late 15-wk (decompensated) ACF groups had significant increases in LVEDD/PWT. Subacute and decompensated stages had a significant upregulation of genes related to inflammation, the ECM, the cell cycle, and apoptosis. These changes were accompanied by neutrophil and macrophage infiltration, nonmyocyte apoptosis, and interstitial collagen loss. At 15 wk, there was a 40-fold increase in the matricellular protein periostin, which inhibits connections between collagen and cells, thereby potentially mediating a side-to-side slippage of cardiomyocytes and LV dilatation. The majority of downregulated genes was composed of mitochondrial enzymes whose suppression progressed from 5 to 15 wk concomitant with LV dilatation and systolic heart failure. The profound decrease in gene expression related to fatty acid, amino acid, and glucose metabolism was associated with the downregulation of peroxisome proliferator associated receptor (PPAR)-␣-related and bioenergetic-related genes at 15 wk. In VO, an early phase of inflammation subsides at 5 wk but reappears at 15 wk with marked periostin production along with the suppression of genes related to PPAR-␣ and energy metabolism. microarray; bioenergetics; congestive heart failure; energy metabolism; gene expression; growth factors/cytokines; peroxisome proliferator-activated receptor-␥ ISOLATED VOLUME OVERLOAD (VO) of the left ventricle (LV) causes eccentric LV remodeling, which ultimately leads to heart failure. There is currently no recommended therapy that attenuates LV remodeling or delays the need for surgery in the isolated VO of aortic or mitral regurgitation (2). Much of the work in animal models of heart failure has been in pressure overload and postmyocardial infarction LV remodeling, and the molecular and cellular mechanisms of isolated VO-induced cardiac remodeling are still poorly understood (2, 6).
ISOLATED VOLUME OVERLOAD (VO) of the left ventricle (LV) causes eccentric LV remodeling, which ultimately leads to heart failure. There is currently no recommended therapy that attenuates LV remodeling or delays the need for surgery in the isolated VO of aortic or mitral regurgitation (2) . Much of the work in animal models of heart failure has been in pressure overload and postmyocardial infarction LV remodeling, and the molecular and cellular mechanisms of isolated VO-induced cardiac remodeling are still poorly understood (2, 6) .
The model of aortocaval fistula (ACF) has been extensively used to study the functional, structural, and molecular underpinnings of adverse eccentric LV remodeling in VO. ACF causes progressive LV dilation, LV wall thinning, and cardiomyocyte elongation (27) , which recapitulates the pathophysiology of isolated VO in humans (2, 6) . In the first 24 h of VO of ACF in the rat, cardiomyocyte-produced TNF-␣ causes the upregulation of a group of genes involved in acute inflammation, mast cell accumulation, matrix metalloproteinase (MMP)-2 activation, and collagen loss (7) . Extracellular matrix (ECM) loss, inflammation, or bioenergetic dysfunction has been implicated at different time points in the pathophysiology of VO (4, 5, 7, 11, (27) (28) (29) 36 ). However, no study has characterized the gene reprogramming of the heart in a systematic and integrated fashion spanning LV adaptation to decompensation in VO.
Here, we relate the gene expression profile to the progression of adverse LV remodeling and systolic dysfunction, where in vivo hemodynamics and echocardiography define the subacute, compensated, and decompensated stages of VO. Distinct up-and downregulated gene sets identify stage-specific changes in the ECM, cell cycle, inflammation, and bioenergetic metabolism that can explain the progression to heart failure over the course of VO.
harvested as previously described by our laboratory (7, 27) . LV free wall tissue was used for all experiments.
RNA isolation. Total RNA was extracted from LV tissue using the RNeasy Fibrous Kit (Qiagen). The integrity of the RNA was evaluated with a Bio-Rad Experion (Bio-Rad, Hercules, CA).
Microarray analysis. Microarray hybridization and subsequent data analysis were performed as previously described (7, 34, 36) . Briefly, single-color microarray analysis was performed on sham and ACF rats (n ϭ 5 rats/group except n ϭ 4 rats/group in the 15-wk ACF group) using Agilent 4 ϫ 44K rat cDNA array chips (Palo Alto, CA). Image files were captured by an Agilent Technologies Microarray Scanner. The .tiff files produced by the scanner were loaded into the image-analysis program Feature Extraction 9.5.1.1 (Agilent Technologies) to extract hybridization intensity data for statistical analysis. All microarray slides were checked for background evenness by viewing the .tiff image on Feature Extraction.
The hybridization intensity data were analyzed using Genespring GX 7.3.1 (Agilent). Data were first normalized using the Genespring normalization scenario for "Agilent FE one-color," which included setting the measurements to Ͻ5.0 to 5.0, normalizing to the 50th percentile of all values on a chip with a "present" flag, and normalizing to the arithmetic mean calculated from sham groups for each gene. The ACF group was compared with the sham group. To identify differentially expressed genes, a list of genes with Ն1.5-fold change was generated first. A Welch's t-test was then conducted on the genes in this list. Genes with a false discovery rate of Ͻ0.05 were used to form the final list of differentially expressed genes for further analyses (1) .
The altered genes were subjected to Gene Ontology (GO) and KEGG pathway analysis with DAVID Bioinformaticresources 2008 (http://david.abcc.ncifcrf.gov/tools.jsp) (9) . DAVID provides a highthroughput and integrative gene functional annotation environment to systematically extract biological themes behind large gene lists. It is based on the established biomedical literature and uses specific approaches to estimate significance (P values) based on nonredundant representations of the microarray chip and to convert the uploaded gene lists to gene lists containing a single value per gene (9) . The P values provide an estimate of the probability that a given enrichment is present by chance alone and are derived using corrections for multiple comparisons (Benjamini and Hochberg false discovery rate).
Quantitative real-time PCR. Quantitative real-time PCR was performed on an iCycler iQ system using SYBR green (Bio-Rad). The primers sequences are shown in the Supplemental Material in Supplemental Table S1 . 1 Briefly, 500 ng total RNA was reverse transcribed in a 20-l reaction volume using an iScript cDNA synthesis kit (Bio-Rad). Samples were run in duplicate, and copy numbers were acquired according to the serial dilution of standards. GAPDH was used as an internal control.
Collagen volume fraction. The interstitial collagen volume fraction (CVF) was determined on picrosirius red-stained sections and quantified as previously described by our laboratory in the rat (7, 26) .
Hydroxyproline content assay. Hydroxyproline content was determined using a colorimetric assay as previously described by our laboratory (36) .
Histopathological analysis. Paraffin-embedded sections (5 m) were dewaxed, boiled in 10 mM sodium citrate buffer for 10 min, blocked with 5% normal serum, and then incubated with antibodies to anti-periostin (rabbit antibody, 1:100), MPO (1:100), or CD68 (1:100) overnight at 4°C. Antibodies to anti-vimentin (1:150) or anti-myosin (1:100) were used as a counterstain to distinguish nonmyocytes and myocytes. After an incubation in the primary antibodies, sections were incubated with Alexa fluor488-or Alexa fluor594-conjugated secondary antibodies (Invitrogen). Nuclei were stained with 4=,6-diamidino-2-phenylindole (Vector). Positive cells were enumerated throughout the LV free wall section (cell numbers/mm 2 ) or on all the fields (10 -20 fields) along epicardium of the LV free wall at ϫ400 magnification (cell numbers/field).
TUNEL assay. The TUNEL assay was performed on paraffinembedded sections using the DeadEnd fluorometric TUNEL kit (Promega, Madison, WI). TUNEL-positive nonmyocytes were counted at ϫ400 magnification in at least 10 fields.
Western blot analysis. Western blot analysis for periostin (goat antibody, 1:2,000), CD14 (1:1,000), HO-1 (1:500), and NF-B p65 (1:1,000) was performed, and bands were quantified as previously described by our laboratory (7) . Tubulin (1:4,000) was used as an internal control.
Gelatin gel zymography. Frozen LV tissue was homogenized in extraction buffer [50 mol/l Tris·HCl (pH 7.6), 1.5 mmol/l NaCl, 0.5 mmol/l CaCl 2, 1 mol/l ZnCl2, 0.01% Brij-35, and 0.25% Triton X-100]. Samples were loaded in a precast 10% gelatin gel, and gel zymography was performed following the manufacturer's instruction (Novex, Invitrogen). A proteolytic band of 62 kDa (active MMP-2) was scanned and quantified with Scion Image 4.0.3. Data are expressed as fold changes of the corresponding control.
Statistics. Data are expressed as means Ϯ SE. Student's t-test was used for echocardiographic, hemodynamics, Western blot analysis, quantitative RT-PCR, cell counting, and CVF data to determine the significance between two groups. Correlation was determined using Pearson's correlation coefficient. P values of Ͻ0.05 were considered statistically significant.
RESULTS

LV remodeling and function at 2, 5, and 15 wk of ACF.
The LV weight-to-tibia length ratio increased 40% at 2 wk and 110% at 15 wk in ACF versus age-matched sham rats. The LV end-diastolic dimension-to-posterior wall thickness ratio (LVEDD/PWT) increased 40% and 80% at 2 and 15 wk, respectively, but did not differ from age-matched sham rats at 5 wk of ACF. In a similar fashion, the LV end-systolic dimension increased 40% and 70% at 2 and 15 wk, respectively, but Ͻ30% at 5 wk of ACF. LV fractional shorting did not decrease until 15 wk, whereas the velocity of circumferential shortening increased at 2 wk, declined to normal levels at 5 wk, and decreased below age-matched sham rats at 15 wk. LV ϩdP/dt max did not differ from sham rats at all time points, whereas LV ϪdP/dt max decreased by 30% at 15 wk of ACF ( Table 1) .
Relationship of upregulated genes at 2, 5, and 15 wk of ACF. The number of upregulated genes at the three time points reflects the nature of the subacute (961 gene transcripts), compensated (176 gene transcripts), and decompensated (2,609 gene transcripts) phases of VO. The Venn diagram shown in Fig. 1A demonstrates the relationship of these upregulated genes in the three phases of VO. Although only a small number of transcripts (176) was upregulated at 5 wk, 42% and 80% of these genes were also upregulated at 2 and 15 wk, respectively, and 40% (74/176) were upregulated at all three time points. Of interest, the cardiac hypertrophy marker natriuretic peptide precursor type A, ECM protein 1, and several matricellular proteins, such as connective tissue growth factor-like protein 5, were upregulated at all three time points.
Relationship of downregulated genes at 2, 5, and 15 wk of ACF. There was less concordance of downregulated genes compared with the analysis of upregulated genes over the three time points. Only 10% (14/120) of the transcripts downregulated at 2 wk were also downregulated at 5 wk, constituting Ͻ5% of downregulated transcripts at 5 wk. Although there was 38% (52/134) concordance of 5-and 15-wk downregulated transcripts, this only accounted for 10% (52/459) of the 15-wk downregulated transcripts. Only eight transcripts were downregulated at all three time points (Fig. 1B) . There was one transcript (caspase recruitment domain family, member 9) that changed direction from 2 to 15 wk (increased at 5 wk and suppressed at 15 wk).
Functional groupings of upregulated genes at 2, 5, and 15 wk of ACF. Eighty percent of the differentially expressed transcripts represented known genes, and the remainder were unannotated expressed sequence tags. Of the upregulated transcripts, at 2 wk, GO term analysis using DAVID revealed an enrichment of genes coding for collagen and noncollagen ECM proteins in addition to genes related to immunological responses, the cell cycle, apoptosis, and angiogenesis (Supplemental Fig. S1A ). The significantly activated signaling pathways were also related to these functions (Supplemental Fig.  S1B ). At 15 wk, all these myocardial responses were further amplified in addition to the activation of genes involved in intracellular signaling (Wnt signaling and G protein-coupled signaling), biopolymer metabolism, and tissue ossification Table S1 for gene annotation.
(Supplemental Fig. S1A ). Thus, the activated signaling pathways at 15 wk were similar to those of 2 wk. However, all these responses were quiescent at 5 wk except for the inflammatory response and the production of some noncollagen ECM proteins (Supplemental Fig. S1, A and B) . Functional groupings of downregulated genes at 2, 5, and 15 wk of ACF. Of the downregulated transcripts, the enriched GO terms were predominantly involved in bioenergetics. Fatty acid and cellular lipid metabolism genes were suppressed as early as 2 wk and progressed from 5 to 15 wk of VO in addition to an increased number of suppressed genes involved in these biological functions (Supplemental Fig. S1C ). A significant suppression of genes involved in substrate transmembrane transportation, mitochondrial fatty acid ␤-oxidation, and energy production was observed at 5 wk and aggravated at 15 wk of ACF (Supplemental Fig. S1C) . Moreover, at 15 wk, the enriched GO term analysis revealed metabolic dysfunction of a broad spectrum of nutrients manifested by the downregulation of genes encoding for enzymes metabolizing amino acids, carbohydrates, monosaccharides, amines, nitrogen compounds, and purine nucleotides (Supplemental Fig. S1C) . Thus, compared with age-matched sham rats, 5-and 15-wk ACF rats had depressed canonical pathways related to amino acid and fatty acid metabolism in the cytoplasm and mitochondria. Peroxisome proliferator-activated receptor (PPAR)-␣ signaling and adipocytokine signaling pathways were also depressed at 15 wk (Supplemental Fig. S1D) .
Validation of microarray by quantitative PCR. Thirty-three of thirty-five genes with a fold change of less than Ϫ1.3 or greater than 1.3 from the 2-wk microarray data were confirmed by quantitative PCR (Fig. 1C) . A further confirmation of microarray data was done by validating genes chosen from different GO term categories. These chosen genes (26 total) were significantly up-or downregulated in microarray data in at least one time point and were then validated in all three time points (3 ϫ 26 cases). All transcripts that were significantly altered in the microarray data at certain time points were confirmed by quantitative PCR at those time points with a similar fold change. In 5 of 18 cases, unaltered genes in the microarray data were significantly changed by quantitative PCR. These cases were spread among the three time points and were usually genes with fold changes close to 1.5-fold and having a high variance as shown by quantitative PCR (Supplemental Table S2 ).
Collagen and matricellular expression. A significant enrichment of genes coding for collagen and noncollagen ECM proteins as well as genes involved in the regulation of ECM production and remodeling were identified in upregulated genes at 2 and 15 wk. In particular, genes promoting 1) ECM accumulation [transforming growth factor (TGF)-␤, connective tissue growth factor (CTGF), and tissue inhibitors of metalloproteinase]; 2) collagen cross-linking (lysyl oxidase); and 3) ECM degradation (MMP-2 and MMP-23) were significantly upregulated at 2 and 15 wk. In contrast, the total number of upregulated genes at 5 wk was markedly decreased compared with 2 and 5 wk of ACF. Most conspicuously, there was a marked decrease in the number of collagen genes and ECM-regulating genes at 5 wk compared with age-matched sham animals (Supplemental Fig. S1A and Fig. 2A ). These categories were not enriched in downreguated genes at any time point (Supplemental Fig. S1C ). Secreted protein, acidic, cysteine-rich (osteonectin) was increased at 2 and 15 wk but not 5 wk, whereas the expression of thrombospondin 4 was increased at only 5 and 15 wk (Fig. 2A) .
Interstitial collagen was decreased in ACF rats versus agematched shams at 5 and 15 wk by picric acid sirius red staining (Fig. 2B) . However, total collage content by hydroxyproline was decreased at 5 wk but not at 15 wk of ACF (Fig. 2C) . The decrease in hydroxyproline at 5 wk was consistent with the decrease in collagen genes, whereas at 15 wk the return to normal age-matched hydroxyproline levels was reflected in extensive LV endocardial perivascular fibrosis (Fig. 2D) , which was not present at 2 or 5 wk of ACF (Fig. 2, B and C) . MMP-2 activity increased at 2 and 15 wk but not 5 wk (Fig.  2E) . The 2-fold increase in periostin mRNA at 2 and 5 wk and the 50-fold increase at 15 wk of ACF were validated by quantitative PCR (Supplemental Table S2 ). Western blot analysis demonstrated barely detectable levels of periostin protein in LV homogenates in sham and 2-wk ACF rats. However, periostin protein increased slightly at 5 wk and was markedly abundant in 15-wk ACF rats (Fig. 3A) . Immunohistological staining of periostin demonstrated patchy positive staining in fibrotic endocardial and perivascular areas in sham rats and 2-and 5-wk ACF rats. However, periostin staining was diffuse in 15-wk ACF rats, surrounding cardiomyocytes as well as perivascular areas (Fig. 3B) .
Inflammatory cell infiltration and gene expression. DAVID analysis revealed a significant enrichment of genes involved in inflammation and the immune response in upregulated genes from 2-and 15-wk ACF rats. At 2 and 5 wk, the majority of these altered genes was related to the regulation of immune and inflammation responses. However, in addition to these categories, at 15 S1C ). Consistent with the greater inflammatory gene expression pattern at 2 and 15 wk, there was a two-and threefold increase in neutrophils (MPO ϩ ) and macrophages (CD68 ϩ ), respectively, without a significant change at 5 wk of ACF (Fig.   4, B and C) . Western blot analysis showed increased NF-B protein p65 and HO-1 expression in 2-and 15-wk ACF rats but not in 5-wk ACF rats (Fig. 4, D and E) .
Progressive downregulation of genes involved in bioenergetics. Quantitative RT-PCR validated the downregulation of key enzymes involved in mitochondrial fatty acid metabolism, fatty acid ␤-oxidation, and glucose metabolism as well as transcription factors controlling the transcription of these enzymes. Retinoid X receptor-␥ (Rxrg) was depressed at 5 wk and was further suppressed at 15 wk of ACF, which was concordant with the decreased PPAR-␣ gene expression. In addition, genes regulated by PPAR-␣ and Rxrg, such as long-chain fatty acid transport protein (FATP), acetyl-CoA carboxylase (Acc2), acetyl-CoA acyltransferase 2 (Acaa2), and medium-chain acyl-CoA dehydrogenase (Mcad) were suppressed at 5 and 15 wk of ACF. Glucose transporter 4 (Glut4) was increased at 2 wk, declined to normal at 5 wk, and decreased at 15 wk of ACF. ATP synthase, H ϩ transporting, mitochondrial F 1 complex, ␣-subunit 1 (Atp5a1) tended to be depressed at 5 wk (fold change: Ϫ1.65 and P ϭ 0.06) and was significantly decreased at 15 wk (Fig. 5A and Supplemental Table S3 ).
Determination of apoptotic cells. Apoptotic cardiomyocytes were rarely seen in the heart of sham or ACF rats (0 -3 rats/heart) at all time points. However, ACF caused an 80% and fivefold increase in TUNEL-positive nonmyocytes versus sham hearts at 2 and 15 wk, respectively, without a significant change at 5 wk (Fig. 5B) . Apoptotic cells were indentified with TUNEL and laminin staining. Many of the apoptotic nuclei were found between cardiomyocytes and were surrounded by laminin, suggesting endothelial cells.
DISCUSSION
The present study demonstrates an early phase of inflammation in VO, which transitions to LV decompensation with marked periostin production along with the downregulation of genes related to PPAR-␣ and energy metabolism. The marked upregulation of periostin can explain ECM dysregulation and LV dilatation, whereas gene programs related to PPAR-␣ downregulation connect the intensified inflammatory response with the profound depression of bioenergetic and metabolism genes in the progression of LV remodeling and heart failure in VO.
Our previous study (7) demonstrated an inflammation-dominated myocardial response within the first 24 h of VO. The present study demonstrates sustained inflammation at 2 wk that subsided at 5 wk and intensifies at 15 wk of VO. Although the inflammatory response is significant at 24 h and 2 wk of VO; 15-wk ACF was marked by greater numbers of infiltrating leukocytes (neutrophils and macrophages) and a more extensive molecular expression of proinflammatory chemokines [Ccl2 and chemokine (C-X-C motif) ligand 2 (Cxcl2)], cytokines (IL-1␤ and IL-16), and receptors [CD14, Tlr4, chemo- Fig. 5 . Real-time PCR analysis of genes involved in bioenergetics and determination of apoptotic cells. A: heat map representing gene expression fold changes in ACF rats versus age-matched sham rats by microarray and real-time PCR at 2, 5, and 15 wk. The gene expression fold changes were imported into GeneSpring for heat map production. Fold changes were set to "null" when they had P values of Ͼ0.05 and are shown in gray. B: quantification of TUNEL-positive nonmyocyte nuclei in ACF and sham rats. n ϭ 5 rats/group except for the 15-wk ACF group, where n ϭ 4. *P Ͻ 0.05 and **P Ͻ 0.01 vs. sham rats.
kine (C-X-C motif) receptor 4 (Cxcr4), Ccr1, Ccr5, Tnfr1, and Tnfr2]. In contrast to all other time points, the inflammatory response at 5 wk was more subtle and not associated with an increase in inflammatory cells, with a normalization of HO-1 expression suggesting a lower oxidative stress burden. The variable intensity of inflammation in the course of VO can, in part, explain the lack of benefit from long-term, continuous neutrophil depletion or anti-TNF-␣ treatment on myocardial remodeling and dysfunction in VO of ACF (16, 19) .
It is now recognized that inflammation initiates cardiac remodeling (20, 35) . Indeed, the more intense inflammatory responses at 2 and 15 wk of ACF were associated with a significant upregulation of gene clusters involved in matricellular, ECM, ECM-cellular interactions, and collagen-related genes, which were markedly decreased at 5 wk. It is also of interest that collagen production by hydroxyproline analysis was decreased at this 5-wk ACF time point and only reached normal age-matched levels at 15 wk of ACF. The finding that collagen production does not keep pace with cardiac hypertrophy has been previously reported by Ruzicka and coworkers (28) in VO of ACF in the rat. In the present study, there was a failure to increase total collagen protein production except for patchy areas of endocardial perivascular fibrosis in the failing 15-wk ACF group. The endocardial perivascular area may represent an early fibrotic change in this ACF model, possibly due to relative endocardial ischemia due to the prolonged elevation of LV diastolic filling pressures. Indeed, patchy LV endocardial fibrosis has been associated with a decreased LV endocardial blood flow reserve in young dogs with chronic LV pressure overload (15) .
Despite the lack of increase in hydroxyproline in 15-wk ACF hearts, gene expression profiling indicates a significant upregulation of profibrogenic cytokines (TGF-␤ and CTGF), growth factors (FGF), and collagen genes (procollagen I and III) at 2 and 15 wk. However, antifibrogenic factors, such as MMPs, tissue kallikreins (kallikrein-7, -3, and -10), and SMAD7, are also increased at 2 and 15 wk of VO. Furthermore, these times points are marked by increased macrophage and neutrophil infiltration as well as increased oxidative stress [manifested by the increase in HO (decycling)-1 (HMOX-1)], which can activate latent MMPs and cause collagen degradation (10) . Indeed, MMP-2 activity increases at the 2-and 15-wk ACF time points but not at the 5-wk ACF time point. Taken together, these results suggest an increase in degradation and a defect in the posttranslational processing of collagen, which led us to investigate other matricellular ECM components that can account for the further LV dilatation at 15 wk.
Matricellular proteins are a class of ECM-related molecules defined through their ability to modulate cell-matrix interactions, usually cell detachment from interstitial collagen (14) . Periostin is a newly recognized matricellular protein not normally expressed in the heart. The function of periostin upon reexpression in the stressed myocardium is currently an area of great interest but also much controversy (8) . In the present study, there is a progressive and marked increase in periostin at 15 wk of VO. Although periostin has been reported to be a critical regulator of fibrosis by altering the deposition and attachment of collagen (3), periostin also inhibits adhesion between fibronectin and myocytes and fibroblasts (3, 8, 14) . Periostin knockout mice develop less fibrosis with chronic pressure overload or postmyocardial infarction and have better LV function (23) . However, lack of periostin makes mice more prone to acute rupture (31) . It is of interest that overexpression of periostin in the rat causes LV dilatation and LV wall thinning (17) , as in our ACF rats at 15 wk, where there is diffuse periostin staining in perivascular areas and between cardiomyocytes. Taken together, it is tempting to speculate that the marked increase in periostin at 15 wk of VO causes disorganized perivascular fibrosis, whereas its inhibitory activity on integrins in cardiomyocytes and/or fibroblasts and their connection to collagen can mediate a side-to-side slippage of cardiomyocytes (24) , resulting in the marked increase in LVEDD/PWT at 15 wk of VO (Fig. 6) . Fig. 6 . Hypothesis for the dynamic molecular and histopathological changes in the ECM and inflammation in the transition to heart failure in isolated volume overload. In the early phase of inflammation, MMP activation transitions to LV "compensation" with stabilization of gene programs of inflammation and MMP activation as the LV end-diastolic dimension-to-posterior wall thickness ratio (LVEDD/wt) normalizes. Subsequent to this point, there is marked periostin production along with downregulation of genes related to peroxisome proliferator-activated receptor (PPAR)-␣ and energy metabolism. The marked upregulation of periostin can explain ECM dysregulation and LV dilatation, while gene programs related to PPAR-␣ downregulation connect the intensified inflammatory response with the profound depression of bioenergetics and metabolism genes in the progression of LV wall stress () and heart failure in volume overload. FA, fatty acid.
In addition to the increase in inflammatory mediators and defects in ECM turnover in the course of VO, the microarray results also demonstrates a progressive decrease in genes encoding enzymes involved in fatty acid transportation and fatty acid oxidation in mitochondria, such as fatty acid transport proteins, Acc2, MCAD, Acca2, and carnitine palmitoyl transferase II, and their transcription regulators, in particular, PPAR-␣ and Rxrg. Other studies (12, 13, 25) have demonstrated that LPS (CD14 and TLR agonists), TNF-␣, and IL-1 decrease fatty acid transport and oxidation in the heart. In addition, Glut4 gene expression is upregulated at 2 wk, returned to normal at 5 wk, and is suppressed at 15 wk of ACF at a time when the key glycolytic enzyme phosphofructokinase and ATP generator Atp5a1 genes are also depressed and associated with the onset of LV systolic failure.
The marked increase in inflammation at 15 wk of ACF was also accompanied by the suppression of a broad spectrum of PPAR-␣-regulated genes and an increase in NF-B p65. A recent study (32) in multiple organs has demonstrated a causeand-effect relationship between PPAR-␣ depression and inflammation. In the mouse heart, knockout of PPAR-␣ results in the expression of 821 differentially expressed genes compared with wild-type mice, which are largely related to inflammation and the immune reaction (32) . The induction of pressure overload in the PPAR-␣ knockout mouse produces a more pronounced hypertrophic growth response and cardiac dysfunction with enhanced inflammation and adverse ECM remodeling mediated through NF-B activation and signaling (32) . The increase in NF-B signaling in 15-wk ACF rats can further suppress PPAR-␣ and Rxr activity and exacerbate the depression in fatty acid metabolic genes (30, 18, 21, 26, 33) . Thus, although the entire course of ACF is associated with variable amounts of inflammation, the concomitant depression in PPAR-␣ at 15 wk can in part explain the intensified inflammatory response and signal the onset of decompensated VO (Fig. 6) . In support of this finding, a PPAR-␣ agonist prevents adverse LV remodeling and improves LV contractility in the dog with VO when administrated 3 mo after the induction of mitral regurgitation (22) .
In conclusion, early inflammation is the underpinning of the adaptation to an acute VO that is halted at 5 wk, concomitant with an increase in LV wall thickness (hypertrophy), but nevertheless associated with a gene expression program consistent with underlying energy and metabolic disturbances. Targeting PPAR-␣ downregulation at this compensated time point in VO may preserve cardiomyocyte function by preventing the onset of intense inflammation and profound bioenergetic dysfunction and metabolic failure. Whether such therapy will also decrease fibroblast expression of periostin and attenuate LV dilatation and systolic dysfunction is the subject of future investigation.
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